BioSpace News Archive

Drug Development

Galapagos NV: Update on Progress in Cystic Fibrosis Programs

The company provided an update on several aspects of its cystic fibrosis (CF) program.

January 3, 2018
·
9 min read
Deals

ASLAN Pharmaceuticals Pays $129M to Acquire Full Global Commercial Rights for Varlitinib From Array BioPharma

The new licensing agreement replaces the prior licensing agreement signed in 2011 to develop and sublicense varlitinib, which did not grant commercial rights to ASLAN.

January 3, 2018
·
4 min read
SMi Group Release: A Focus on the Areas of the Biggest Growth, Hitting on Key Topics and the Most Recent Studies in the PFS Field

Just 2 weeks remain until SMi opens its doors to host the conference, “Pre-Filled Syringes Europe” set to take place in London on 17 - 18 January.

January 3, 2018
·
1 min read
Onxeo to Attend Key Investor and Partnering Conferences in H1 2018

Onxeo today announced that its management team will attend the following key investor and partnering conferences in the first half of 2018.

January 3, 2018
·
2 min read
Business

ASLAN Pharma Acquires Full Global Commercial Rights for Varlitinib From Array BioPharma

The new licensing agreement replaces the prior licensing agreement signed in 2011 to develop and sublicense varlitinib, which did not grant commercial rights to ASLAN.

January 3, 2018
·
4 min read
Biotech Beach

BioPhotas Launches the Newest Model of the Celluma Series

BioPhotas announces the commercial introduction of the Celluma HOME, a fourth model in the Celluma Series of light therapy devices.

January 3, 2018
·
2 min read
Drug Development

Insmed Announces Additional Data from ALIS (Amikacin Liposome Inhalation Suspension) Phase III Clinical Program for Adult Patients with Treatment Refractory NTM Lung Disease Caused by MAC and Reports Progress With Commercial Preparations

The company announced new data from its Phase 3 clinical program for adult patients with treatment refractory NTM lung disease.

January 3, 2018
·
18 min read
Genetown

Momenta and Mylan Announce Development Strategy for M710, a Proposed Biosimilar to EYLEA (aflibercept)

The companies plan to initiate a pivotal clinical trial in patients in the first half of 2018.

January 3, 2018
·
6 min read
Biotech Bay

Varian to Discuss New Reporting Standards

Varian today announced that it will webcast a conference call to discuss its transition to the new Accounting Standard Codification 606.

January 3, 2018
·
1 min read
Biotech Beach

AmpliPhi Biosciences Announces Positive Interim Results for Single-Patient Expanded Access Program Utilizing AB-SA01 and AB-PA01

Six of the seven patients (86%) achieved treatment success (physician’s assessment), defined as complete resolution or significant improvement of baseline signs and symptoms.

January 3, 2018
·
8 min read